6 orthopedic medtech companies earning investor interest

Becker’s has reported on six spine and orthopedic medtech companies raising money through investors so far in 2023:

Advertisement

1. Paris-based Ganymed Robotics raised an additional 15 million Euros, or approximately $15.9 million, in Series B funding, the company said Jan. 4.

2. Saluda Medicine, which is behind the Evoke spinal cord stimulation system, received a $150 million equity financing round, the company said April 13.

3. Biomaterials company Sealonix has closed on $20 million in series A funding for the development of its next generation of hemostatic sealants for surgical use. The initial product is a sealant patch providing rapid hemostasis for abdominopelvic and orthopedic procedures.

4. Vertos Medical raised $26 million in Series C funding, the medtech company said June 7. The funding, led by Norwest Venture Partners, will help commercial expansion of the Mild procedure for lumbar spinal stenosis patients.

5. Augmedics closed $82.5 million in series D financing to support the growth of Xvision, the medtech company said June 27.

6. CurvaFix raised $39 million in series C financing and named a new CEO, the orthopedic devicemaker said July 14.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • SurGenTec’s ION-C earned FDA 510(k) clearance for ION-C navigation instruments with the ION-C posterior cervical facet fixation implant, according to…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.